The SARS coronavirus S glycoprotein receptor binding domain: Fine mapping and functional characterization

Virology Journal

Volumn 2, Issue , 2005, Pages

  Chakraborti, Samitabh ^a   Prabakaran, Ponraj ^a   Xiao, Xiaodong ^a   Dimitrov, Dimiter S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACE2 RECEPTOR; ALANINE; GLUTAMINE; RECEPTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN S RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE PROTEIN; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRUS ENVELOPE PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; DATA ANALYSIS; GENE MUTATION; GLYCOSYLATION; IMMUNE RESPONSE; MOLECULAR WEIGHT; MUTAGENESIS; RECEPTOR BINDING; SARS CORONAVIRUS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHEMICAL STRUCTURE; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYLOGENY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; VIRUS ATTACHMENT;

SARS CORONAVIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; GLYCOSYLATION; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDYL-DIPEPTIDASE A; PHYLOGENY; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; SARS VIRUS; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT;

EID: 25644445907     PISSN: 1743422X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-422X-2-73     Document Type: Article

References (23)

1. Dimitrov DS: Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol 2004, 2:109-122.
2. Holmes KV: SARS-associated coronavirus. N Engl J Med 2003, 348:1948-1951.
3. Lai MM, Cavanagh D: The molecular biology of coronaviruses. Adv Virus Res 1997, 48:1-100.
4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al.: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348:1953-1966.
5. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, et al.: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-1399.
6. Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS: The SARS-CoV S glycoprotein: expression and functional characterization. Biochem Biophys Res Commun 2003, 312:1159-1164.
7. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al.: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454.
8. Wong SK, Li W, Moore MJ, Choe H, Farzan M: A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 2004, 279:3197-3201.
9. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P: Characterization of severe acute respiratory syndromeassociated coronavirus (SARS-CoV) spike glycoproteinmediated viral entry. Proc Natl Acad Sci U S A 2004, 101:4240-4245.
10. Babcock GJ, Esshaki DJ, Thomas WD Jr, Ambrosino DM: Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 2004, 78:4552-4560.
11. Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, et al.: Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA 2004, 101:6641-6646.
12. Bosch BJ, van der ZR, de Haan CA, Rottier PJ: The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003, 77:8801-8811.
13. Wang P, Chen J, Zheng A, Nie Y, Shi X, Wang W, et al.: Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Commun 2004, 315:439-444.
14. Dimitrov DS: The secret life of ACE2 as a receptor for the SARS virus. Cell 2003, 115:652-653.
15. Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, et al.: ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 2004, 279:17996-18007.
16. Guy JL, Jackson RM, Acharya KR, Sturrock ED, Hooper NM, Turner AJ: Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 2003, 42:13185-13192.
17. Prabakaran P, Xiao X, Dimitrov DS: A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem Biophys Res Commun 2004, 314:235-241.
18. Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et al.: Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 2005, 24:1634-1643.
19. Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, et al.: Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 2004, 101:2536-2541.
20. Zhang MY, Choudhry V, Xiao X, Dimitrov DS: Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS. Curr Opin Mol Ther 2005, 7:151-156.
21. McGinnis S, Madden TL: BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 2004, 32:W20-W25.
22. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, et al.: Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003, 31:3497-3500.
23. Lee B, Richards FM: The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971, 55:379-400.